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5Foreword 
Healthy mothers and babies are the foundation of a society. 
The best way to ensure the health of mothers and babies 
is to develop universal, well-functioning and high quality 
antenatal care. 
This pocket guide is for all ANC (antenatal care) professionals, 
traditional birth attendants and family workers, training 
institutions, students, INGOs, and NGOs. With this new pocket 
guide, all professionals working in ANC will have the best 
evidence on how to screen, treat and guide pregnant women 
in Somaliland to ensure a safe pregnancy and childbirth for 
every woman in Somaliland.
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81 Introduction
Preventable, pregnancy-related morbidity and mortality are unacceptably 
high in Somaliland. Effective interventions at reasonable costs could pre-
vent most maternal deaths, life-threatening morbidity and complications. 
However, the goal in maternity care is not only to avoid morbidity and 
mortality but also to improve the health and well-being of girls, women 
and their families.
Female genital mutilation/cutting (FGM/C) comprises all procedures 
that involve removal of the external female genitalia, or other injury to 
the female genital organs for non-medical reasons. Girls and women who 
have experienced FGM/C should be provided with high quality health care. 
The practice violates medical ethics because it is harmful. Thus it is never 
acceptable that health care providers perform FGM/C.
This pocket guide is based on ANC guidelines (2019) for Somaliland and 
is designed for every professional working in ANC. It is based on the WHO 
guidelines on routine ANC for pregnant women and adolescent girls. This 
pocket guide presents evidence-based, relevant and up-to-date guidelines 
that can be used by doctors, midwives, nurses and other workers including 
traditional birth attendants in their daily work. The book is presented in a 
format that can be easily carried by professionals during their daily work 
and can be available at clinics to help guide the management of pregnant 
women.
92 Nutritional interventions
2.1 Healthy eating and physical activity 
WHY?
  Undernourishment, being overweight and obesity increase the risk 
of pregnancy complications such as low birth-weight neonates, 
hypertension, gestational diabetes mellitus and  
neonatal macrosomia.
HOW?
  Provide good advice on balanced energy and protein dietary 
supplementation.
  Encourage daily physical activity.
  Measure pregnant women’s weight (kilograms with one decimal, 
e.g. 52.1 kg) and height (meter with two decimals, e.g. 1.62 m) and 
calculate their Body Mass Index.
  Measuring height: 
• Remove shoes, hair ornaments etc.
• The back of the head, shoulder blades, buttocks and heels should 
touch or be in line with the wall.
10
Figure 1. Measure height without shoes and hair ornaments.
  Measuring weight:
• Remove shoes and heavy over clothes.
Figure 2. Measure weight without shoes and heavy over clothes.
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  Calculating the Body Mass Index:
• Weight in kilograms (kg) divided by height in meters squared  
(kg/m2)
• An example: 51.0 kg and 1.62 m --------BMI=51/1.622=19.43
Normal weight gain during pregnancy
Weight of woman Body Mass Index Aimed weight gain
Underweight BMI < 18.5 kg/m² 12.5–18 kg
Normal weight BMI 18.5–24.9 kg/m² 11.5–16 kg
Overweight BMI 25–29.9 kg/m² 7–11.5 kg
Obese BMI > 30 kg/m² 5–9 kg
2.2  Anaemia, iron and folic acid    
 supplementation
WHY?
  Maternal anaemia and iron deficiency are associated with increased 
risks of postpartum haemorrhages, low birth weights, small-
for-gestational age babies, puerperal sepsis, preterm births and 
increased risks of maternal and infant mortality.
HOW?
  Take a full blood count test. If full blood count testing is unavailable, 
test with a haemoglobinometer.
  Take a haemoglobin sample from the fingertip. First clean the finger, 
then prick the fingertip with a lancet. Wipe away the first drop of 
blood. Collect a blood drop with a capillary tube or pipette. Insert 
the test strip into the haemoglobin device and read the Hb result.
  Screen haemoglobin in pregnancy weeks 12, 26 and 36.
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  Limits for diagnosing anaemia: week 12: less than 11.0 g/dl,  
week 26: less than 10.5 g/dl, week 36: less than 11.0 g/dl.
  Ask all pregnant women to take 60 mg of iron and 400 mcg  
(0.4 mg) of folic acid or multiple micronutrient supplements  
(tablets containing various vitamins including iron and folic acid) 
daily for the prevention of anaemia.
  If diagnosed with anaemia, ask pregnant women to take 120 mg  
of oral iron and 0.4 mg of folic acid daily.
  Give folate (vitamin B9) to decrease the risk of neural tube 
deficiency.
How to treat anaemia?
Symptoms Treatment
Severe 
anaemia
Haemoglobin < 7.0 g/dl
and/or severe palmar and 
conjunctival pallor
or any pallor with 
breathlessness in rest and/
or respiratory rate with more 
than 30 breaths/minute and/
or if the mother tires easily
Refer urgently to hospital
Moderate 
anaemia
Haemoglobin 7.0–11.0 g/dl 
or palmar or conjunctival 
pallor
120 mg of oral iron and 0.4 
mg of folic acid daily for 
three months
(or double the dose of 
a combination tablet 
containing 60 mg of iron and 
0.4 mg of folic acid from one 
tablet daily to one tablet 
twice daily) 
Check the compliance to 
treatment
Reassess in 4–6 weeks and  
if the anaemia persists, refer 
to hospital
Consider antimalarial and/or 
anthelminthic treatment.
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Parasitic infections affecting anaemia
WHY?
  Parasitic infections can cause iron-deficiency related anaemia by 
feeding on the blood and causing further bleeding by releasing 
anticoagulant compounds. These may also reduce the absorption 
of iron and other nutrients by causing anorexia, vomiting and 
diarrhoea.
  Preventive anthelminthic treatment reduces the burden of other 
infections, e.g. HIV, malaria and TB and treatment reduces infant 
and maternal mortality.
HOW?
  Diagnose with a laboratory test by counting the concentration of 
eggs in the stools.
  Give a single-dose of Albendazole 400 mg or Mebendazole 500 mg 
after the first trimester if:
• living in areas where the baseline prevalence of hookworm and/or 
T. trichiura infection is 20% or more among pregnant women, and 
• where anaemia is a severe public health problem, with  
a prevalence of 40% or higher among pregnant women.
  In areas where hookworm and/or T. trichiura are endemic, treat 
all pregnant women after the first trimester to reduce the worm 
burden in those who are moderately to heavily infected. 
  Provide health promotion about hygiene, such as hand washing, 
use of footwear and proper disposal of faeces at the same.
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2.3 Calcium supplementation
WHY?
  Calcium is needed for the development of bones and teeth and 
functioning of muscles and nerves.
  It is also associated with the development of hypertensive disorders 
in pregnancy. 
  Calcium must be obtained from food or supplements.
HOW?
  Provide advice on calcium-rich foods, e.g. camel milk, yoghourt, 
milk, spinach, okra, dates, oranges, and white beans.
  If the calcium intake is low and there is a risk of pre-eclampsia 
provide advice on taking calcium supplementation 1.5–2.0 g divided 
into three doses per day, starting from pregnancy week 20 until  
the end of pregnancy.
  Iron and calcium supplements should be administered at least  
two hours apart in order to avoid interactions.
Figure 3. Provide advice on a healthy meal including calcium-rich, iron-rich and rich 
in vitamin A foods.
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2.4 Vitamin A supplementation 
WHY?
  Vitamin A deficiency can cause night-time blindness, contribute to 
the development of anaemia and may be associated with low birth 
weights.
HOW?
  Recommend a healthy balanced diet and foods rich in vitamin A, 
e.g. carrots, sweet potatoes, liver, beef and pumpkins.
  If a woman suffers from night blindness in the current pregnancy 
or if 5% or more of women in a population have a history of night 
blindness in pregnancy, ask the pregnant woman to take 10,000 IU 
vitamin A per day, or a weekly dose of 25,000 IU. 
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3  Maternal and foetal   
 assessment
3.1  Asymptomatic bacteriuria (ASB) and   
 urinary tract infection (UTI)
WHY?
  Treating ASB and UTIs can prevent low birth weights, premature 
births and pyelonephritis.
HOW? 
  Take a midstream urine culture or gram-staining. If not available, 
use a dipstick test. Ask the pregnant woman to clean herself and 
then to collect urine “mid-stream” in a clean cup. Dip the test stick 
into the urine. Wait for 1 minute and read the result according to  
the colour which you can find on the test package.
  If the protein and/or leucocytes and/or nitrites and/or haemoglobin 
are positive, it can indicate ASB/UTI in pregnancy. If the leukocytes 
in the test are positive, ask the pregnant woman to come again to 
the MHC and take another sample within one week.
  If the second test is still positive, refer to the doctor for a midstream 
urine culture for diagnosing asymptomatic bacteriuria (ASB) or 
urinary tract infections (UTI).
  Antibiotic treatment is recommended only after diagnosing  
ASB/UTI. 
  Use a five- to seven-day course of pivmecillinam, nitrofurantoin or 
beta-lactam for treatment. Nitrofurantoin can be used only until 
end of pregnancy week 37.
  Take a control urine sample after one week from the end of  
the antibiotic treatment.
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  With the presence of fever (over 37,9°C), suspect pyelonephritis and 
refer to the hospital. In case of pyelonephritis use cefuroxime 0.75–
1.5 g x 3 i.v.
  Group B streptococcus (GBS) bacteriuria indicate heavy colonisation 
and may not be eradicated with antibiotics. Intrapartum antibiotic 
treatment is recommended with GBS colonisation to prevent early 
neonatal infections.
Figure 4. Test urine sample with a dipstick test, wait for 1 minute and read the result.
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3.2 Domestic violence 
WHY?
  Domestic violence affects women’s physical and mental health 
through direct pathways, such as injury, and indirect pathways, 
such as chronic health problems that arise from prolonged stress. 
HOW?
  Conditions that can be caused or complicated by DV include 
traumatic injuries, repeated STIs, an intrusive partner or 
husband present during consultations, unexplained or repeated 
genitourinary symptoms, adverse reproductive outcomes including 
multiple unintended pregnancies and/or terminations, symptoms 
of depression and anxiety, delay in seeking MCH, alcohol and other 
substance use, adverse birth outcomes and self-harm, suicidality, 
symptoms of depression and anxiety.
  Use the midwife-led continuity of care (MLCC) model to offer a way 
of achieving a positive, trusting and empathetic relationship with 
pregnant women and also to identify and prevent DV.
  When safe to do so (i.e. the partner is not present) and when 
identification of DV is followed by an appropriate response,  
ask the women about violence face-to-face or with a written or 
computer-based questionnaire. 
  Hargeisa Group Hospital has a unit for victims of violence.  
ANC professionals can refer women who have been exposed to DV  
to the unit or consult the unit about available services.
19
Figure 5. Ask the women about domestic violence when safe to do so.
3.3 Hyperglycaemia and gestational diabetes  
 mellitus (GDM)
WHY? 
  Elevated levels of blood sugar increase the risk of pre-eclampsia 
and macrosomia for the baby. 
  Diabetes mellitus in pregnancy means that the diabetes has pre-
existed before pregnancy. Gestational diabetes mellitus (GDM) 
means a glucose intolerance of a variable degree with onset or 
first recognition during pregnancy. Diabetes mellitus in pregnancy 
differs from GDM in that hyperglycaemia is more severe and does 
not resolve after pregnancy as it does with GDM. 
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HOW?
  Screen for risk factors for diabetes and test for hyperglycaemia. 
  The usual window for diagnosing GDM is between 24 and 28 weeks 
of gestation.
  If glucose is high in the test (hyperglycaemia), ≥5.1 mmol/l refer to 
the hospital (or a well-equipped MCH, maternal and child health 
clinic) for conducting an oral glucose tolerance test (OGTT) and 
treatment. 
  If an oral glucose tolerance test, OGTT is possible, use that instead 
of a quick test. If not, the fasting blood glucose with a quick test 
should be tested before pregnancy week 28.
  Provide advice on healthy eating and physical activity.
Risk factors:
BMI >30kg/m2 Age >35 years
Previous GDM Polycystic ovary syndrome, PCOS
Previous macrosomia Previous spontaneous abortion
Family history of DM Previous foetal death
Glucose ++ or above on one occasion 
or + on two or more occasions while 
utilising a Urine dipstick test
Multiparity, more than three children
Figure 6. Take a blood glucose test from fingertip and read the result. 
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The diagnosis of gestational diabetes mellitus (GDM) and diabetes mellitus 
in pregnancy at any time during pregnancy should be based on any one of 
the following values:
Gestational diabetes 
mellitus (GDM)
Diabetes mellitus 
in pregnancy
Fasting plasma glucose = 5.1–6.9 mmol/l  
(92–125 mg/dl) 
≥ 7.0 mmol/l  
(126 mg/dl)
1-h post 75g oral glucose load  >=10.0 mmol/l  
(180 mg/dl)
2-h post 75g oral glucose load = 8.5–11.0 mmol/l  
(153–199 mg/dl) 
 ≥ 11.1 mmol/l  
(200 mg/dl)
Random plasma glucose ≥ 11.1 mmol/l 
(200 mg/dl) in 
the presence of 
diabetes symptoms
 
3.4 Hypertension, proteinuria and  
 pre-eclampsia
WHY?
  Approximately one quarter of maternal deaths and near misses are 
caused by pre-eclampsia and eclampsia, thus blood pressure and 
proteinuria must be checked at every routine ANC contact.
HOW?
  Educate the mother and her family to recognise the critical signs 
of pre-eclampsia: headache, blurred vision, convulsions, loss of 
consciousness, epigastric pain and breathing difficulties. 
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  Blood pressure is considered elevated if the systolic blood pressure 
is equal or higher than 140 mmHg OR the diastolic blood pressure 
equal to or higher than 90 mmHg. 
  Elevated blood pressure needs to be monitored more intensively or 
immediately lowered depending on the severity of the findings. 
  Recognising the type of hypertensive disorder is important, because 
they are often managed differently.
  Hypertension in pregnancy can be diagnosed if the systolic pressure 
(SBP) is 140–159 mmHg and/or diastolic blood pressure (DBP) is  
90–109 mmHg.
  The blood pressure is in a severe range if the systolic blood pressure 
(SBP) is 160 mmHg or higher and/or the diastolic blood pressure 
(DBP) is 110 mmHg or higher.
Figure 7. Measure blood pressure after sitting for a while and on left arm. 
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Elevated blood pressure without accompanying findings is likely to be either:
1)  chronic hypertension, which occurs before 20 weeks of gestation or
2)  gestational hypertension, which occurs for the first time after 20  
 weeks of gestation, during labour and/or within 48 hours of giving  
 birth.
Management depends on the severity of the hypertension
Blood pressure Blood pressure, mmHg Treatment
Normal SBP 90–139 mmHg and 
DBP 60–89 mmHg
Normal follow up, ask the mother to 
come to the MCH as usual.
Elevated SBP 140–159 mmHg 
and/or 
DBP 90–109 mmHg 
No need to refer to hospital.
Ask the mother to come to the MCH 
after three days and take her blood 
pressure and test the urine using  
the dipstick method even though 
she may have no symptoms.
Educate the mother to recognise 
the critical signs of pre-eclampsia 
and advise her to go to the MCH or 
hospital if she has the signs.
High SBP 160 mmHg or 
higher and/or DBP 110 
mmHg or higher.     
Refer the mother right away to  
a hospital. 
Consult physician or hospital about 
antihypertensive medication.
If hypertension is associated with symptoms such as headaches, blurred 
vision, convulsions, loss of consciousness, epigastric pain, breathing 
difficulties or any laboratory findings such as proteinuria, elevated liver 
enzymes, elevated creatinine or thrombocytopenia, the possibility for 
3)  chronic hypertension with superimposed pre-eclampsia or  
4) pre-eclampsia-eclampsia must be taken into consideration.
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Mild pre-eclampsia Treatment
SBP 140–159 mmHg and/or  
DBP 90–109 mmHg AND 
proteinuria 2+ on dipstick
Monitor blood pressure, symptoms, 
proteinuria, and foetal condition twice a week.
Provide advice concerning the danger signs.
Severe pre-eclampsia Treatment
SBP 160 mmHg or higher and/or 
DBP 110 mmHg or higher  
(after 20 weeks of pregnancy)
and/or proteinuria 2+ on 
dipstick and/or any of the 
symptoms:
• Headaches (increasing 
frequency, unrelieved by 
regular analgesics) 
• Vision changes  
(e.g. blurred vision) 
• Oliguria (passing less than  
400 mL of urine in 24 hours)
• Upper abdominal pain 
(epigastric pain or pain in  
right upper quadrant) 
• Difficulty breathing (rales 
may be observed during 
auscultation of lungs due to 
fluid in the lungs) 
• Nausea and vomiting
• Hyperreflexia or clonus
Refer to hospital.
Consult physician or hospital about 
antihypertensive medication.
If further laboratory analyses are available, severe findings can include:
Proteinuria ≥ 300 mg in a 24-hour urine sample
protein/creatinine ratio ≥ 0.3
Liver enzymes (transaminases) more than twice the normal range
Serum creatinine ≥ 1.1 mg/dL or a doubling of serum creatinine 
in the absence of other renal disease
Platelets < 100 000 cells/mcL (100 x 10^9/L)
25
• Convulsions with signs of pre-eclampsia indicate eclampsia. 
• Convulsions can occur regardless of the severity of hypertension. 
• Treat all pregnant women with convulsions as if they have 
eclampsia until another diagnosis is confirmed. 
• Convulsions represent a medical emergency which need to be 
treated immediately on-site.
3.5 Preterm birth
WHY?
  Identification and prevention of imminent pre-term births reduce 
long-term health effects and perinatal deaths related to pre-term 
birth.
HOW?
  Risk factors for preterm births are multiple pregnancy, infections 
and chronic conditions such as diabetes and high blood pressure. 
  Women with suspected or detected imminent preterm birth should 
be referred to hospital for further examination and treatment. 
Examinations include a cervical examination to detect cervical 
dilatation. Tocolytic medication and corticosteroid therapy can be 
used in the hospital. 
  Women with imminent preterm birth should be referred to hospital 
also for adequate childbirth care and preterm new-born care.
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3.6 Malpositions and malpresentations 
WHY?
  If the foetus is in an abnormal position or presentation, pregnancy 
may result in prolonged or obstructed labour, maternal mortality 
and perinatal mortality.
HOW?
  Carry out a careful vaginal and/or abdominal palpation 
and ultrasound if available, to identify malpositions and 
malpresentations. 
  Refer to hospital. Delivery with a foetus in a malposition or 
malpresentation should take place in a hospital with the ability to 
perform an emergency caesarean section. 
  The presence of a skilled birth attendant is essential for a safe 
vaginal breech birth. 
  Attempt an external cephalic version if a breech presentation is 
present at or after 37 weeks, and vaginal birth is possible, facilities 
for emergency caesarean section are available, membranes are  
intact and amniotic fluid is adequate and there are no complications.
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Figure 8. Carry out abdominal palpation. The mother should lay down in a semi-
recumbent/ dorsal position (at a 45-degree angle), with her knees slightly bent and 
arms by her side. 
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3.7 Multiple pregnancy 
WHY? 
  Multiple pregnancies are associated with greater severe maternal 
morbidity and maternal/perinatal mortality due to obstetric 
complications such as pre-eclampsia, post-partum haemorrhage, 
and preterm birth. 
HOW?
  Carry out a careful vaginal and/or abdominal palpation and 
ultrasound if available, to identify multiple pregnancies.
  Handle antenatal care in the hospital. Timely access to a safe 
caesarean section is required.
3.8 HIV and syphilis 
WHY?
  Testing and counselling reduces maternal morbidity, foetal loss, 
and neonatal mortality/morbidity due to HIV and syphilis.
HOW? 
  Use a screening test including both HIV and syphilis at the first 
trimester and counsel for HIV. 
  Offer oral pre-exposure prophylaxis (PrEP) containing tenofovir 
disoproxil fumarate (TDF) as an additional HIV prevention.
  Use ART (antiretroviral therapy) in all pregnant women diagnosed 
with HIV, because it improves individual health outcomes, prevents 
mother-to-child transmissions of HIV, and prevents the horizontal 
transmission of HIV from the mother to an uninfected sexual 
partner.
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  Screen all pregnant women for syphilis again in late pregnancy. 
Women who do not have test results at delivery should be tested or 
retested at the MCH or hospital just before the delivery. 
  Treat syphilis with penicillin. The women’s partners should also be 
tested and treated with penicillin if needed. Provide education on 
how to prevent re-infection.
3.9 Tuberculosis (TB)
WHY?
  Respiratory diseases such as tuberculosis, are an important cause 
of morbidity and mortality in pregnant women in Somaliland.
  TB increases the risk of preterm birth, perinatal death and other 
pregnancy complications. 
HOW?
  Screen using chest radiography because there is no significant risk. 
Notice: national guidelines for the use of radiography should still be 
followed.
  If TB is diagnosed, all household contacts and other close contacts 
should also be systematically screened for TB.
  People living with HIV should also be systematically screened for 
active TB at each contact at the health-care facility.
  Treat pregnant women with TB with antibiotics. With the exception 
of streptomycin, first line anti-TB drugs are safe for use in 
pregnancy: streptomycin is ototoxic to the foetus and should not be 
used during pregnancy.
  Pyridoxine supplementation is recommended for all pregnant or 
breastfeeding women taking isoniazid for TB.
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3.10 Symphysis-fundal height (SFH)    
  measurement and abdominal palpation 
WHY? 
  Use SFH to access foetal growth. At the same time check the 
position of the foetus. If the SFH results differ from the average 
level, this may indicate a growth abnormality of the foetus.
HOW?
  The mother should be in a semi-recumbent position (at a 45-degree 
angle) on a firm surface, with an empty bladder, and expose enough 
of the abdomen to allow a thorough two-handed palpation.
  Run a non-elastic tape measure along the longitudinal axis of  
the uterus (not correcting to the midline) to the highest point of  
the uterus.
  When using customised growth charts, the curves should not flatten 
towards end of pregnancy; uncompromised babies should continue 
growing until delivery. Measure in the same way, and if there is 
static/slow growth, refer to hospital to obtain an ultrasound scan.
Figure 9. Measure symphysis-fundal height with tape measure along  
the longitudinal axis of the uterus in the same way every time.
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Figure 10. Check growth of the baby using the result of the SFH-measurement and 
comparing it with the customised growth chart. The curves of the measurement 
results should not flatten towards end of pregnancy.
Reference: Acta obst. et gynec. Scandinavica / 1978
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3.11 Ultrasound scan 
WHY?
  One ultrasound scan should be done before 24 weeks of gestation 
(early ultrasound) to estimate the gestational age, improve  
the detection of foetal anomalies and multiple pregnancies,  
reduce the induction of labour for post-term pregnancy, and 
improve a woman’s pregnancy experience overall.
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4 Preventive measures
4.1 Tetanus toxoid immunization status and  
 vaccine 
WHY?
  The vaccination of a mother with tetanus toxoid (TT) protects  
the child from infection for the first weeks as well.
HOW?
  The immunisation status should be checked during the first 
antenatal contact. If the mother has not been vaccinated or her 
vaccination status is unknown, the mother should be vaccinated 
accordingly: 
1st vaccination, 
TT1
2nd vaccination, 
TT2
3rd vaccination, 
TT3
4th vaccination, 
TT4
5th vaccination, 
TT5
at the first 
ANC contact 
(or anywhere, 
1 dose 
immediately)
at the second 
contact  
(4 weeks after 
the TT1)
6 months after 
the TT2
1 year after 
TT3 or during 
a subsequent 
pregnancy
1 year after 
TT4 or during 
a subsequent 
pregnancy
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4.2  Prevention of malaria 
WHY?
  Malaria infection during pregnancy is a major public health problem 
with substantial risks for the mother, her foetus, and the new-born.
HOW?
  Promote the use of insecticide-treated nets, treat cases effectively, 
and in areas with moderate to high transmission of Plasmodium 
falciparum administer IPTp-SP.
  Start dosing in the second trimester, and give doses at least one 
month apart, with the objective of ensuring that at least three 
doses are received. 
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5  Common physiological  
 symptoms
5.1  Nausea and vomiting
 – Recommend ginger, chamomile, mint oil, lemon oil, vitamin B6 
and/or acupuncture to relief nausea and vomiting.
5.2  Heartburn
 – Provide advice on diet and lifestyle to prevent and relieve 
heartburn. Antacids (e.g. magnesium carbonate and aluminium 
hydroxide preparations) can be offered to women with 
troublesome symptoms that are not relieved by lifestyle 
modification.
5.3 Leg cramps
 – Provide advice on the use of magnesium, calcium or  
non-pharmacological treatment options for the relief of leg cramps.
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5.4  Back and pelvic pain
 – Recommend regular exercise throughout pregnancy to prevent 
low back and pelvic pain and if available, also recommend 
physiotherapy, support belts and acupuncture.
5.5  Constipation
 – Provide advice on dietary modifications, wheat bran or other fibre 
supplements to relieve constipation.
5.6  Varicose veins and oedema
 – Provide advice on compression stockings, leg elevation, rest and 
water immersion to manage varicose veins and oedema.
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6 Health systems
Different kinds of interventions can be employed to improve the utilisation 
and quality of ANC. Eight ANC contacts is a long-term target, and at least 
four contacts as the short-term target. 
6.1  Woman-held case notes
Give each pregnant woman her own case notes during pregnancy to 
improve continuity, quality of care and a positive pregnancy experience.
6.2  Group antenatal care
Organize group care as an alternative to individual antenatal care for 
pregnant women. It is good to use an appropriate room to deal with group 
sessions, for example the rooms should be large enough, well-ventilated 
or sheltered spaces with adequate seating. A private area should be 
available for examinations, and opportunities should be given for private 
conversations.
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Figure 11. Organize group care meetings in a room large enough or outdoors. 
6.3  Women’s groups
Organize women’s groups in your MCH or together with other MCHs 
nearby and provide opportunities for women to discuss their needs during 
pregnancy, including barriers to accessing care, and to increase support 
among pregnant women. 
6.4  Home visits
Organize antenatal home visits and mobilise community workers who 
are working together with you to improve antenatal care utilisation and 
perinatal health outcomes, particularly in rural settings with minimal 
access to health services.
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6.5  Task-shifting 
Share your tasks in antenatal care between various health-care providers 
and lay people. For example the distribution of recommended nutritional 
supplements can be shifted from midwives to lay health workers.
6.6  Staff in rural and remote areas
Take care that MoHD organizes and employs qualified health workers also 
in rural and remote areas. 
6.7 Fathers or partners in maternity care
Invite fathers/partners and encourage mothers to ask their partners to 
participate during antenatal contacts, delivery and postnatal contacts. 
Promotion of the role of men as partners and fathers is essential for their 
involvement and support. 
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7  Antenatal care contact  
 schedules
The short-term target for Somaliland is to achieve at least four ANC contacts 
to improve maternal and child health and to avoid maternal, perinatal and 
infant deaths.
Scheduled contacts:
1.  12 weeks
2.  26 weeks
3.  32 weeks
4.  36–38 weeks
7.1  Short-term target with four ANC contacts
Checklist of the four contacts  ▶ ▶ ▶
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CHECKLIST OF THE FOUR CONTACTS
1st Contact at 12 weeks
Basic information and counselling
• Mother: name, age, phone number, town/village
• Medical history of the mother: existing medical conditions, 
medications, number of pregnancies and births, problems with 
previous pregnancies, FGM/C
• Current pregnancy: last periods, trimester of first contact, EDD 
(estimated date of delivery), planned place for delivery, place for 
emergency delivery
• Nutritional counselling
• Iron and folic acid supplementation
• Assessment of significant symptoms: overall impression, pains, 
changes to vision, urinary problems, breathing difficulties, nausea 
and vomiting, heartburn, vaginal bleeding, vaginal discharge,  
leg cramps, oedema, severe itching, mental well-being
• Information about DV (domestic violence)
• Psychosocial support
Clinical examinations
• Height 
• Weight
• Calculate BMI (kg/m2) 
• Blood pressure mmHg 
• Fasting blood glucose test or OGTT (contact 1 or 2 according to 
findings)
• Urine dipstick test 
• Haemoglobin (g/dl)
• HIV-ART, syphilis, tetanus vaccination
• Ultrasound 
• Abdominal palpation: size of uterus, scars on abdomen,  
pains during palpation
• If there is a proper Doppler foetal monitor available, the foetal heart 
rate can be checked. Otherwise this can be checked on the 2nd visit. 
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CHECKLIST OF THE FOUR CONTACTS
2nd Contact at 26 weeks
Counselling
• Nutritional counselling
• Iron, folic acid, calcium supplementation
• HIV-ART
• Anthelminthic treatment
• Assessment of significant symptoms: overall impression, pains, 
changes to vision, urinary problems, breathing difficulties, nausea 
and vomiting, heartburn, vaginal bleeding, vaginal discharge,  
leg cramps, oedema, severe itching, foetal movements felt,  
mental well-being
• Information about DV (domestic violence)
• Breastfeeding counselling
• Psychosocial support
Clinical examinations
• Weight
• Blood pressure mmHg 
• Fasting blood glucose test or OGTT (If not done during the 1st 
contact or hyperglycaemia has been detected during the first 
contact)
• Urine dipstick test
• Haemoglobin (g/dl) 
• SFH measurement: size of uterus, growth of the baby
• Foetal heart rate
• Abdominal palpation: size of uterus, scars on abdomen,  
pains with palpation
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CHECKLIST OF THE FOUR CONTACTS
3rd Contact at 32 weeks
Counselling
• Nutritional counselling
• Iron, folic acid, calcium supplementation
• HIV-ART
• Intent to breastfeed (and counselling on this issue)
• Anthelminthic treatment
• Assessment of significant symptoms: overall impression, pains, 
changes to vision, urinary problems, breathing difficulties, nausea 
and vomiting, heartburn, vaginal bleeding, vaginal discharge,  
leg cramps, oedema, severe itching, foetal movements felt,  
mental well-being
• Information about DV (domestic violence)
• Psychosocial support
Clinical examinations
• Weight  
• Blood pressure mmHg 
• Urine dipstick test 
• SFH measurement: size of the uterus, growth of the baby
• Foetal heart rate
• Abdominal palpation: growth of the baby, position of the baby: 
cephalic/breach/unknown, scars on abdomen, pains during 
palpation
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CHECKLIST OF THE FOUR CONTACTS
4th contact at 36 weeks
Counselling
• Nutritional counselling
• Iron, folic acid, calcium supplementation
• HIV-ART
• Assessment of significant symptoms: overall impression, pains, 
changes to vision, urinary problems, breathing difficulties, nausea 
and vomiting, heartburn, vaginal bleeding, vaginal discharge,  
leg cramps, oedema, severe itching, foetal movements felt, 
maternal well-being
• Information about DV (domestic violence)
• Breastfeeding counselling
• Counselling for birth preparedness
• Counselling on the importance of postpartum contacts 
• Psychosocial support
Clinical examinations
• Weight
• Blood pressure mmHg 
• Urine dipstick test
• Haemoglobin (g/dl) 
• SFH measurement: size of uterus, growth of the baby
• Foetal heart rate
• Abdominal palpation: growth and position of the baby: cephalic/
breach/unknown, scars on abdomen, pains with palpation
If the first ANC contact is later than 12 weeks, the collection of basic 
information and the performance of clinical examinations generally 
planned for the first contact should be done then in addition to what is 
planned for the week the contact occurs in. Counselling should also cover 
all aspects that would have been dealt with starting from 12 weeks.
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7.2  Long-term target with eight ANC contacts
The long-term target for Somaliland is to achieve eight ANC contacts 
to improve maternal and child health, to avoid maternal, perinatal and 
infant deaths, and for pregnant women in Somaliland to have a positive 
pregnancy experience.
Scheduled contacts:
1. 12 weeks
2. 20 weeks
3. 26 weeks
4. 30 weeks
5. 34 weeks
6. 36 weeks
7. 38 weeks
8. 40 weeks 
Checklist of the eight contacts  ▶ ▶ ▶  
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CHECKLIST OF THE EIGHT CONTACTS
1st Contact at 12 weeks
Basic information and counselling
• Mother: name, age, phone number, town/village
• Medical history of the mother: existing medical conditions, 
medications, number of pregnancies and births, problems with 
previous pregnancies, FGM/C
• Current pregnancy: last periods, trimester of first contact, EDD, 
planned place of birth, place for emergency childbirth
• Nutritional counselling
• Iron and folic acid supplementation
• Assessment of significant symptoms: overall impression, pains, 
changes to vision, urinary problems, breathing difficulties, nausea 
and vomiting, heartburn, vaginal bleeding, vaginal discharge,  
leg cramps, oedema, severe itching, mental well-being
• Information about DV (domestic violence)
• Psychosocial support
Clinical examinations
• Height 
• Weight
• Calculate BMI (kg/m2) 
• Blood pressure mmHg 
• Fasting blood glucose test or OGTT (contact 1, 2 or 3 according to 
findings)
• Urine dipstick test 
• Haemoglobin (g/dl)
• HIV-ART, syphilis, tetanus vaccination
• Ultrasound 
• Abdominal palpation (size of uterus, scars on abdomen, pains with 
palpation)
• If there is a proper Doppler foetal monitor available, the foetal heart 
rate can be checked. Otherwise this can be checked on the 2nd visit. 
46
CHECKLIST OF THE EIGHT CONTACTS
2nd Contact at 20 weeks
Counselling
• Nutritional counselling
• Iron, folic acid, calcium supplementation
• HIV-ART
• Anthelminthic treatment
• Assessment of significant symptoms: overall impression, pains, 
changes to vision, urinary problems, breathing difficulties, nausea 
and vomiting, heartburn, vaginal bleeding, vaginal discharge,  
leg cramps, oedema, severe itching, foetal movements felt,  
mental well-being
• Information about DV (domestic violence)
• Psychosocial support
Clinical examinations
• Weight  
• Blood pressure mmHg 
• Fasting blood glucose test or OGTT (if not done during the 1st contact 
or hyperglycaemia has been detected during the first contact)
• Urine dipstick test 
• Ultrasound if not done during the first contact
• SFH measurement: size of the uterus, growth of the baby
• Foetal heart rate
• Abdominal palpation: size of the uterus and growth of the baby, 
scars on abdomen, pains with palpation
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CHECKLIST OF THE EIGHT CONTACTS
3rd Contact at 26 weeks
Counselling
• Nutritional counselling
• Iron, folic acid, calcium supplementation
• HIV-ART
• Anthelminthic treatment
• Assessment of significant symptoms: overall impression, pains, 
changes to vision, urinary problems, breathing difficulties, nausea 
and vomiting, heartburn, vaginal bleeding, vaginal discharge,  
leg cramps, oedema, severe itching, foetal movements felt,  
mental well-being
• Information about DV (Domestic violence)
• Psychosocial support
Clinical examinations
• Weight  
• Blood pressure mmHg 
• Fasting blood glucose test or OGTT (if not done during 1st or 2nd 
contact or hyperglycaemia has been detected at these contacts)
• Urine dipstick test 
• Haemoglobin (g/dl) 
• SFH measurement: size of the uterus, growth of the baby
• Foetal heart rate
• Abdominal palpation: size of the uterus and growth of the baby, 
scars on abdomen, pains with palpation
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CHECKLIST OF THE EIGHT CONTACTS
4th Contact at 30 weeks
Counselling
• Nutritional counselling
• Iron, Folic acid, calcium supplementation
• HIV-ART
• Intent to breastfeed and counselling
• Assessment of significant symptoms: overall impression, pains, 
changes to vision, urinary problems, breathing difficulties, nausea 
and vomiting, heartburn, vaginal bleeding, vaginal discharge,  
leg cramps, oedema, severe itching, foetal movements felt,  
mental well-being
• Information about DV (domestic violence)
• Psychosocial support
Clinical examination
• Weight  
• Blood pressure mmHg 
• Urine dipstick test 
• SFH measurement: size of the uterus, growth of the baby
• Foetal heart rate
• Abdominal palpation: growth and position of the baby: cephalic/
breach/unknown, scars on abdomen, pains with palpation
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CHECKLIST OF THE EIGHT CONTACTS
5th Contact at 34 weeks
Counselling
• Nutritional counselling
• Iron, Folic acid, calcium supplementation
• HIV-ART
• Assessment and counselling of significant symptoms: overall 
impression, pains, changes to vision, urinary problems, breathing 
difficulties, nausea and vomiting, heartburn, vaginal bleeding, 
vaginal discharge, leg cramps, oedema, severe itching, foetal 
movements felt, mental well-being
• Information about DV (domestic violence)
• Counselling for breastfeeding
• Psychosocial support
Clinical examinations
• Weight  
• Blood pressure mmHg 
• Urine dipstick test 
• SFH measurement: size of the uterus, growth of the baby
• Foetal heart rate
• Abdominal palpation: position of the baby: cephalic/breach/
unknown, scars on abdomen, pains with palpation
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CHECKLIST OF THE EIGHT CONTACTS
6th Contact at 36 weeks
Counselling
• Nutritional counselling
• Iron, folic acid, calcium supplementation
• HIV-ART
• Assessment and counselling of significant symptoms: overall 
impression, pains, changes to vision, urinary problems, breathing 
difficulties, nausea and vomiting, heartburn, vaginal bleeding, 
vaginal discharge, leg cramps, oedema, severe itching, foetal 
movements felt, mental well-being
• Information about DV (domestic violence)
• Counselling for breastfeeding
• Counselling for birth preparedness
• Counselling on the importance of post-natal contacts
• Psychosocial support 
Clinical examinations
• Weight  
• Blood pressure mmHg 
• Urine dipstick test
• Haemoglobin (g/dl) 
• SFH measurement: size of the uterus, growth of the baby
• Foetal heart rate
• Abdominal palpation: growth and position of the baby: cephalic/
breach/unknown, scars on abdomen, pains with palpation
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CHECKLIST OF THE EIGHT CONTACTS
7th Contact at 38 weeks
Counselling
• Nutritional counselling
• Iron, folic acid, calcium supplementation
• HIV-ART
• Assessment and counselling of significant symptoms: overall 
impression, pains, changes to vision, urinary problems, breathing 
difficulties, nausea and vomiting, heartburn, vaginal bleeding, 
vaginal discharge, leg cramps, oedema, severe itching, foetal 
movements felt
• Information about DV (Domestic violence)
• Counselling for breastfeeding
• Counselling for birth preparedness
• Counselling on the importance of post-natal contacts
• Psychosocial support 
Clinical examinations
• Weight  
• Blood pressure mmHg 
• Urine dipstick test 
• SFH measurement: size of the uterus, growth of the baby
• Foetal heart rate
• Abdominal palpation: growth and position of the baby: cephalic/
breach/unknown, scars on abdomen, pains with palpation
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CHECKLIST OF THE EIGHT CONTACTS
8th Contact at 40 weeks
Counselling
• Nutritional counselling
• Iron, folic acid, calcium supplementation
• HIV-ART
• Assessment and counselling of significant symptoms: overall 
impression, pains, changes to vision, urinary problems, breathing 
difficulties, nausea and vomiting, heartburn, vaginal bleeding, 
vaginal discharge, leg cramps, oedema, severe itching, foetal 
movements felt, mental well-being
• Information about DV (domestic violence)
• Counselling for breastfeeding
• Counselling for birth preparedness
• Counselling on the importance of post-natal contacts
• Psychosocial support 
Clinical examinations
• Weight  
• Blood pressure mmHg 
• Urine dipstick test 
• SFH measurement: size of the uterus, growth of the baby
• Foetal heart rate
• Abdominal palpation: growth and position of the baby: cephalic/
breach/unknown, scars on abdomen, pains with palpation
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ANC Contact Schedules
ANC contact schedules Short-term target: 4 contacts
1st 2nd 3rd 4th
Basic information and 
counselling
12 
weeks
26 
weeks
 32 
weeks
36 
weeks
Mothers’ information x
Medical history x
Current pregnancy x
Nutritional counselling x x x x
Iron and folic acid 
supplementation x x x x
Calcium supplementation x x x
HIV–ART x x x
Anthelminthic treatment x x
Assessment of significant 
symptoms x x x x
Information about domestic 
violence x x x x
Counselling for breastfeeding x x x
Counselling for birth 
preparedness x
Counselling on the importance 
of postpartum contacts x
Psychosocial support x x x x
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ANC contact schedules Long-term target: 8 contacts
1st 2nd 3rd 4th 5th 6th 7th 8th
Basic information and 
counselling
 12 
weeks
20 
weeks
26 
weeks
30 
weeks
34 
weeks
 36 
weeks
 38 
weeks
 40 
weeks
Mothers’ information x
Medical history x
Current pregnancy x
Nutritional counselling x x x x x x x x
Iron and folic acid 
supplementation x x x x x x x x
Calcium supplementation x x x x x x x
HIV-ART x x x x x x x
Anthelminthic treatment x x
Assessment of significant 
symptoms x x x x x x x x
Information about  
domestic violence x x x x x x x x
Counselling for  
breastfeeding x x x x
Counselling for  
birth preparedness x x x
Counselling on the 
importance of postpartum 
contacts
x x x
Psychosocial support x x x x x x x x
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Clinical  
examinations
1st 2nd 3rd 4th 1st 2nd 3rd 4th 5th 6th 7th 8th
12 
weeks
26 
weeks
32 
weeks
36 
weeks
12 
weeks
20 
weeks
26 
weeks
30 
weeks
34 
weeks
36 
weeks
38 
weeks
40 
weeks
Height x x
Weight x x x x x x x x x x x x
Calculate  
the BMI  
(kg/m2)
x x
Blood pressure 
mmHg x x x x x x x x x x x x
Fasting  
blood glucose  
test or OGTT
x (x) x (x) (x)
Urine dipstick test x x x x x x x x x x x x
Haemoglobin 
(g/dl) x x x x x x
HIV-ART and  
syphilis test x x
Check status of  
tetanus 
vaccination
x x
Ultrasound x x (x)
SFH measurement x x x x x x x x x x
Foetal heart rate x x x x x x x x x x
Abdominal palpation x x x x x x x x x x x x
(x) if needed or not done during the previous contact
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8  Breastfeeding
WHY? 
  Exclusive breastfeeding for the first six months and breastfeeding 
until the baby reaches two years are recommended to improve  
the health of the baby. Exclusive breastfeeding means that the baby 
is fed only with breast milk without any additional food or drink, not 
even water and it is recommended until the baby is six months old.
  Breastfeeding 
• provides all the energy and nutrients that the baby needs for  
the first months of life
• promotes sensory and cognitive development
• reduces child mortality, because it protects the infant against 
infectious diseases such as diarrhoea or pneumonia and  
has health benefits that extend into adulthood
• helps a quicker recovery during illness
• has health benefits that extend into adulthood, for example  
it reduces the risk of heart disease and type 2 diabetes
• also improves maternal health and well-being. It helps protect 
against post-partum haemorrhage, postpartum depression and  
it reduces the risk of ovarian cancer and breast cancer.
• is a safe way of feeding, adds family and national resources, and  
is safe for the environment.
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HOW?
  Give active support and information and empower mothers to 
establish and sustain appropriate breastfeeding practices,  
already during pregnancy. 
  Initiation of breastfeeding within the first hour of life
  Breastfeeding on demand–that is, as often as the child wants,  
day and night
  No use of bottles, teats or pacifiers
Figure 12. Recommend exclusive breastfeeding for the first six months and 
breastfeeding until the baby reaches two years.
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9  Birth spacing
WHY?
  Birth spacing and ensuring access to preferred contraceptive 
methods for women and couples reduces maternal and infant 
morbidity and mortality. 
  Birth spacing
• allows the spacing of pregnancies and limits the size of families 
when needed or wished 
• prevents unintended pregnancies, including those of young and 
older women who face increased risks related to pregnancy
• allows people to make informed choices about their sexual and 
reproductive health. It represents an opportunity for girls and 
women to participate in education and in public life, including 
paid employment in non-family organisations.
• enables parents to invest more in each child
• has an effect on infant mortality rates, because it can prevent 
closely-spaced and ill-timed pregnancies and births. Pregnant 
adolescents are more likely to have preterm or low birth-weight 
babies, which leads to higher rates of neonatal mortality among 
them.
• reduces the risk of unintended pregnancies among women living 
with HIV. This has an impact on the number of infected babies and 
orphans.
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HOW?
  Discuss birth spacing with the family already during the antenatal 
period.
  Choosing the right method for a woman depends on her health 
situation and smoking habits.
  Choose from the various birth-spacing methods: pills, implants, 
injections, patches and intrauterine devices. Also the traditional 
methods, such as the calendar method are available. 
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10  Female genital   
 mutilation or cutting  
 (FGM/C)
WHY?
  There are several health risks of FGM/C, e.g. haemorrhage, pain, 
urine retention, genital tissue swelling, infections and problems 
with wound healing. Long-term complications include increased 
risk of urinary tract infections, bacterial vaginosis, dyspareunia and 
obstetric complications. 
  Women with FGM/C may have various emotional and psychosocial 
difficulties, e.g. post-traumatic stress disorder, anxiety, 
somatisation, phobia, and low self-esteem. Childbirth can activate 
the negative feelings that FGM/C has caused. 
  FGM/C violates girls’ and women’s rights to life, physical integrity 
and health.
HOW?
  Awareness raising of FGM/C: Community participatory learning, 
multifaceted discussion groups, and action cycles with women’s 
groups should be provided as part of education and communication 
interventions with regard to the health risks and violation of human 
rights related to FGM/C. 
  Psychological support for survivors of FGM/C: All girls and women 
who have undergone FGM/C should be offered psychological 
support and sexual counselling for preventing and treating 
emotional and psychosocial difficulties and sexual dysfunction.
  Ending FGM/C in the health sector: FGM/C by health-care providers 
or reinfibulation should not be performed in any case.
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  High quality care and defibulation for survivors of FGM/C:  
Women with FGM/C should be offered quality health care and  
the opportunity for defibulation with local anaesthesia,  
to enable the prevention and treatment of urologic and  
obstetric complications, either antepartum or intrapartum.
Figure 13. Talk about FGM/C with a woman and her husband. Women with FGM/C 
should be offered the opportunity for defibulation.
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H ealthy mothers and babies are the foundation of a society. The best way 
to ensure the health of mothers and babies 
is to develop universal, well-functioning 
and high quality antenatal care (ANC).  
This pocket guide is for all ANC professionals, traditional birth 
attendants and family workers, training institutions, students, 
INGOs, and NGOs. With this new pocket guide, all professionals 
working in ANC will have the best evidence on how to screen, 
treat and guide pregnant women in Somaliland to ensure a safe 
pregnancy and childbirth for every woman in Somaliland.
